雌激素受体β在慢传输性便秘发病中的作用及机制探讨
|
摘要
慢传输性便秘(slow transit constipation, STC)是较常见的一类功能性顽固性便秘,发病机制不清,严重者需要手术切除全(次全)结肠。流行病学调查表明,STC多发于女性,男女比例为1:9,提示性激素可能在STC的发生及发展过程中起着重要的作用。雌激素作为最重要的性激素之一,除对生殖系统的重要作用外,对消化系统、心血管系统、泌尿系统、中枢神经系统、免疫系统等都发挥重要的调控作用。雌激素是与其特异性受体-雌激素受体(estrogen receptor,ER)结合而发挥生理作用的。ER包括ERα及ERβ两种亚型,每种亚型又包括多种同分异构体。研究发现ERβ是结肠内主要表达的雌激素受体,其表达水平决定肠道对雌激素及其拮抗剂的反应。我们前期免疫组化研究发现,女性STC患者乙状结肠粘膜层ERβ表达较对照组明显减少,提示ERβ表达降低可能与STC的发病有关。但ERβ在结肠壁其它部位的分布及表达如何?STC患者结肠存在哪几种ERβ同分异构体,其表达如何?ERβ在STC发病中的作用如何?国内外尚未见报道。
近年来的研究证实Cajal间质细胞(interstitial cells of Cajal, ICC)是介于肠神经系统和平滑肌细胞之间的一类特殊的间质细胞,是胃肠道慢波的起搏细胞,对肠神经信号传递到平滑肌起重要的调控作用,探索ICC的病理变化可望成为STC发病机制研究的突破点。c-kit是ICC的特异性标志物,属酪氨酸激酶受体家族第三亚类,与其配体干细胞因子(stem cell factor, SCF)结合后所启动的信号通路,对ICC的发育、分化及表型维持至关重要。中和抗体阻断c-kit可导致ICC数目减少,肠道慢波消失。目前研究发现STC患者结肠ICC显著减少,并存在形态异常,同时发现结肠c-kit表达也显著降低,提示STC患者结肠ICC数量和形态异常变化与c-kit基因表达的异常有关,但这种异常是否与ERβ有关联?其具体机制如何?国内外尚未见报道。
近年来研究发现,阻断ER可以导致c-kit mRNA几乎不表达,因此,ER有可能参与调控c-kit信号通路。为此,我们将进一步从转录和翻译水平研究STC患者及模型大鼠结肠ERβ表达,以及阻断ERβ信号通路后结肠c-kit及ICC的变化,观察ERβ对ICC的影响,探讨ERβ影响结肠动力的机制,为今后深入探讨STC的发病机制及其激素治疗提供新思路。
目的:
1.研究STC患者血清性激素变化及ERβ在乙状结肠的分布,从转录和翻译水平探讨STC患者乙状结肠ERβ基因表达的变化。
2.建立STC大鼠模型,研究STC大鼠血清性激素及结肠ERβ表达变化。
3.阻断ERβ信号通路,检测大鼠结肠肌电的变化,观察大鼠结肠ICC数量及c-kit表达的变化,探讨ERβ在ICC异常变化中的作用。
方法:
1.采用电化学发光法检测STC患者血清性激素的变化;采用免疫组织化学方法观察STC患者乙状结肠ERβ的分布和表达变化;采用RT-PCR及Western blot技术检测STC患者乙状结肠ERβ同分异构体mRNA及ERβ蛋白的表达变化。
2.建立STC大鼠模型,采用电化学发光法检测STC大鼠血清性激素的变化;采用电生理方法检测STC大鼠结肠离体肌条慢波频率及振幅;采用RT-PCR及Western blot技术检测STC大鼠结肠ERβ同分异构体mRNA及ERβ蛋白的表达变化。
3.采用他莫昔芬(tamoxifen,TAM)阻断ERβ信号通路,通过电生理方法检测大鼠在体及离体结肠肌电慢波频率及振幅的变化;采用RT-PCR技术检测大鼠结肠c-kit mRNA的表达变化;采用Western blot技术检测大鼠结肠c-kit蛋白的表达变化;采用免疫组织化学及免疫荧光染色方法观察大鼠结肠ICC的分布、形态及ICC的数量变化。
结果:
1.电化学发光法检测显示,STC患者血清促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E2)、泌乳素(PRL)、孕酮(P)及睾酮(Testo)与对照组相比均无显著性差异(P>0.05)。
2.免疫组化结果显示,ERβ在STC患者及对照组乙状结肠粘膜层、肌间神经丛及粘膜下神经丛都有表达,环肌层及纵肌层未见表达。与对照组相比,STC患者乙状结肠粘膜层、肌间神经丛及粘膜下神经丛ERβ表达均明显减少(p<0.01)。
3.RT-PCR结果显示,STC患者及对照组乙状结肠均表达ERβ1、ERβ2、ERβ5 mRNA,而ERβ3、ERβ4 mRNA未见表达。与对照组比较,STC组ERβ1、ERβ2、ERβ5 mRNA表达显著降低(p<0.01)。Western blot结果显示,STC患者乙状结肠ERβ蛋白表达明显低于对照组(p<0.01)。
4.成功建立STC大鼠模型,电生理方法检测显示,STC大鼠结肠离体肌条慢波频率及振幅明显低于对照组(p<0.05)。
5.电化学发光法检测显示,STC大鼠血清促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E2)、孕酮(P)及睾酮(Testo)与对照组相比均无显著性差异(P>0.05),泌乳素(PRL)检测量太少,无意义。
6.RT-PCR结果显示,STC大鼠及对照组结肠均表达rERβ1、rERβ2 mRNA,而rERβ1δ3、rERβ2δ3及rERβ1δ4 mRNA均未见表达。与对照组相比,STC大鼠结肠rERβ1、rERβ2 mRNA表达均显著降低(p<0.01)。Western blot结果显示,STC大鼠结肠ERβ蛋白表达明显低于对照组(p<0.01)。
7.阻断ERβ信号通路,电生理检测发现大鼠在体及离体结肠肌电慢波频率及振幅均显著降低(p<0.05)。RT-PCR结果显示,实验组大鼠结肠c-kit mRNA表达显著降低(p<0.01)。Western blot结果显示,实验组大鼠结肠c-kit蛋白表达显著降低(p<0.01)。免疫组化结果显示,结肠ICC主要包括四个部分,即粘膜下环肌层表面ICC、环肌层ICC、肌间丛ICC和纵肌层ICC,实验组大鼠结肠各部分ICC均显著减少,残存的ICC突起变短、变钝。免疫荧光染色分析结果显示,实验组大鼠结肠粘膜下环肌层表面ICC、环肌层ICC、肌间丛ICC和纵肌层ICC阳性面积均显著减少,结肠环肌层和纵肌层ICC几乎消失。
结论:
1.STC患者及模型大鼠血清性激素与对照组均无明显差异。提示血清性激素与STC的发病无直接联系。
2.STC患者乙状结肠肌间及粘膜下神经丛ERβ表达较对照组均明显降低。提示肌间及粘膜下神经丛ERβ表达降低可能和STC发病有关。
3.STC患者及模型大鼠结肠ERβ蛋白及ERβ同分异构体mRNA表达较对照组均显著降低。提示STC发病与ERβ基因在转录和(或)翻译水平的异常表达有关。
4.ERβ表达异常可能通过影响c-kit信号通路进而影响ICC数量和形态,导致STC发病。
Background:
Slow transit constipation (STC) is a colonic motor disorder, which is characterized by measurably delayed movement of materials through the colon. Although abnormalities in the neuronal networks of the colon have been demonstrated in patients with STC, the aetiology of it remains unclear. The severity of its symptoms and the failure of the conservative therapy ultimately led to colectomy for some patients with STC.
Health surveys revealed that chronic constipation caused by slow transit is common in women with an F/M ratio of 9:1. The cause and mechanism responsible for this syndrome are unknown. Among the female hormones, estrogen is one of the most important female homones,it can have an indispensable effect on body with estrogen receptor (ER), ER have two kinds of recptors, ie, ERαand ERβ. Studies reported ERβis the major ER in colon.That is to say, ERβcan determine the effect of estrogen and its antagonist on colon. Previous studies in our laboratories have shown that the expression of ERβprotein decreased greatly in mucous layer of sigmoid colon of patients with STC though immunohistochemistry method, which indicated ERβwas related to the pathogenesis of STC.
Interstitial cells of Cajal (ICC) have been shown to be the pacemaker cells of the intestine and have been implied in the pathogenesis of a number of gastrointestinal motility dysfunction including idiopathic slow transit constipation. A major breakthrough in this field was the discovery that the tyrosine kinase receptor c-kit are critical in the normal development, maturation, and maintenance of phenotype of ICC, and ICC can be reliably identified by c-kit immunohistochemical technique. Blockade of c-kit with neutralized antibody could induce transdifferentiation of ICC to a smooth muscle phenotype, and intestinal slow waves disappear. A loss-of-function mutation of c-kit results in depletion of stem cells and ICC, while its gain-of-function mutation results in their oncogenesis. Several studies indicate that ICC decreased in the colon of patients with STC, and the expression of c-kit mRNA was also reduced. So, abnormal expression of c-kit gene may disturb the SCF/c-kit signal pathway, and contribute to the alteration of ICC in STC. However, the mechanism is unknown.
Recent study suggested the blockade of ER signaling can lead to the decreased expression of c-kit mRNA, and ER may regulate c-kit signal pathway. So, we want to investigate further the expression of ERβin patients and rats with STC in transcription or translation phase. we study the changes of c-kit and ICC though blocking the ERβsignal pathway, and explore whether ERβhas any effects on ICC.
Objective: The aims of this study were:
(1) To investigate the sexual homones in patients and rats with STC, and to determine if sexual homones are abnormal.
(1) To detect the expression of ERβprotein and its isoform mRNA within the colon of patients and rats with STC, and to determine if the expression of ERβare abnormal.
(2) To explore the motility of rat colon though blocking the ERβsignal pathway, and further to investigate the expression of c-kit and ICC in the colon of experimental group, and to determine whether ERβhas any effects on ICC.
Methods:
Twenty patients with STC and Twenty age-matched controls were studied. The sexual homones were detected by Chemiluminescence. The distribution and expression of ERβwere observed with immunohistochemistry. Western blotting and Revers-transcriptional polymerase chain reaction (RT-PCR) technique were employed to determine the expression of ERβprotein and ERβisoform mRNA. An experimental rat model of STC was established with Rhubarb. Chemiluminescence was used to detect sexual homones. Frequency and amplitude of colonic slow waves were examined though electrophysiology. Western blotting and RT-PCR technique were employed to investigate the expression of ERβprotein and ERβisoform mRNA. Though blocking ERβpathway with tamoxifen (TAM), frequency and amplitude of colonic slow waves were examined though electrophysiology in both groups. Western blotting and RT-PCR technique were employed to determine the expression of c-kit protein and c-kit mRNA. The distribution and configuration of ICC were observed with immunohistochemistry. With an immunofluorescence staining, ICC were examined with fluorescence microscope and the area occupied by ICC were calculated with an image analysis system.
Results:
(1) Chemiluminescence displayed that FSH, LH, E2, PRL, P and Testo in patients with STC had no differences with that of control group (P>0.05).
(2) Immunohistochemistry displayed that ERβwas detected in mucous layer, myenteric nerve plexus and submucous nerve plexus, but not detected in muscular layer in the sigmoid colon of patients with STC and the controls. ERβwas mainly expressed in cytoplasm. The expression of ERβin each of the three regions in STC group decreased significantly compared with the control group (P<0.05).
(3) The RT-PCR results indicated that the ERβ1, ERβ2 and ERβ5 mRNA were detected in the sigmoid colon of patients with STC and the controls, but ERβ3 and ERβ4 mRNA were not detected. In comparison with the control group, the expression of ERβprotein and ERβ1, ERβ2 and ERβ5 mRNA of STC group significantly declined (P<0.01).
(4) Western blotting technique showed that ERβprotein reduced markedly in the sigmoid colon of patients with STC compared with the controls (P<0.01).
(5) An experimental rat model of STC was established with Rhubarb for 3 months. The frequency and amplitude of colonic slow waves were decreased in vitro (P<0.05).
(6) Chemiluminescence displayed that FSH, E2, LH, P and Testo in rats with STC had no differences with that of control group (P>0.05), and PRL was too little to be detected.
(7) The RT-PCR results indicated that the rERβ1 and rERβ2 mRNA were detected in the two groups,but rERβ1δ3, rERβ2δ3 and rERβ1δ4 mRNA were not detected. In comparison with the control group, the expression of rERβ1 and rERβ2 mRNA in the colon of rats with STC significantly declined (P<0.01).
(8) Western blotting technique showed that ERβprotein in the colon of rats with STC reduced markedly compared with the controls (P<0.01).
(9) Though blocking the ERβsignal pathway with TAM, the frequency and amplitude of slow waves of the experimental group were reduced significantly in vitro and in vivo compared with the control group(P<0.05). The RT-PCR and Western blot results indicated that the expression of c-kit mRNA and c-kit protein also decreased significantly (P<0.01). Immunohistochemistry displayed that ICC were located in the four regions (ICC-LM, ICC-MP, ICC-CM, ICC-SMB), and ICC in the experimental group appeared blunted and shorter compared with the controls. Immunofluorescence staining showed that the percentage of the area occupied by ICC in SMB, MP regions were significantly decreased while compared with the controls (p<0.01), and ICC in CM and LM regions almost can not be find.
Conclusions:
(1) Our studies revealed the sexual homones in patients and rats with STC had no differences with that in controls, which indicated that the serum sexual homones level had no direct relationship with STC.
(2) The reduction of ERβin myenteric nerve plexus and submucous nerve plexus may relate to the pathogenesis of STC.
(3) Abnormal expression of ERβgene in the colon of patients and rats with STC at transcription or translation phase may relate to the pathogenesis of STC.
(4) Abnormal expression of ERβgene may disturb the c-kit signal pathway, and contribute to the alteration of ICC.
近年来的研究证实Cajal间质细胞(interstitial cells of Cajal, ICC)是介于肠神经系统和平滑肌细胞之间的一类特殊的间质细胞,是胃肠道慢波的起搏细胞,对肠神经信号传递到平滑肌起重要的调控作用,探索ICC的病理变化可望成为STC发病机制研究的突破点。c-kit是ICC的特异性标志物,属酪氨酸激酶受体家族第三亚类,与其配体干细胞因子(stem cell factor, SCF)结合后所启动的信号通路,对ICC的发育、分化及表型维持至关重要。中和抗体阻断c-kit可导致ICC数目减少,肠道慢波消失。目前研究发现STC患者结肠ICC显著减少,并存在形态异常,同时发现结肠c-kit表达也显著降低,提示STC患者结肠ICC数量和形态异常变化与c-kit基因表达的异常有关,但这种异常是否与ERβ有关联?其具体机制如何?国内外尚未见报道。
近年来研究发现,阻断ER可以导致c-kit mRNA几乎不表达,因此,ER有可能参与调控c-kit信号通路。为此,我们将进一步从转录和翻译水平研究STC患者及模型大鼠结肠ERβ表达,以及阻断ERβ信号通路后结肠c-kit及ICC的变化,观察ERβ对ICC的影响,探讨ERβ影响结肠动力的机制,为今后深入探讨STC的发病机制及其激素治疗提供新思路。
目的:
1.研究STC患者血清性激素变化及ERβ在乙状结肠的分布,从转录和翻译水平探讨STC患者乙状结肠ERβ基因表达的变化。
2.建立STC大鼠模型,研究STC大鼠血清性激素及结肠ERβ表达变化。
3.阻断ERβ信号通路,检测大鼠结肠肌电的变化,观察大鼠结肠ICC数量及c-kit表达的变化,探讨ERβ在ICC异常变化中的作用。
方法:
1.采用电化学发光法检测STC患者血清性激素的变化;采用免疫组织化学方法观察STC患者乙状结肠ERβ的分布和表达变化;采用RT-PCR及Western blot技术检测STC患者乙状结肠ERβ同分异构体mRNA及ERβ蛋白的表达变化。
2.建立STC大鼠模型,采用电化学发光法检测STC大鼠血清性激素的变化;采用电生理方法检测STC大鼠结肠离体肌条慢波频率及振幅;采用RT-PCR及Western blot技术检测STC大鼠结肠ERβ同分异构体mRNA及ERβ蛋白的表达变化。
3.采用他莫昔芬(tamoxifen,TAM)阻断ERβ信号通路,通过电生理方法检测大鼠在体及离体结肠肌电慢波频率及振幅的变化;采用RT-PCR技术检测大鼠结肠c-kit mRNA的表达变化;采用Western blot技术检测大鼠结肠c-kit蛋白的表达变化;采用免疫组织化学及免疫荧光染色方法观察大鼠结肠ICC的分布、形态及ICC的数量变化。
结果:
1.电化学发光法检测显示,STC患者血清促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E2)、泌乳素(PRL)、孕酮(P)及睾酮(Testo)与对照组相比均无显著性差异(P>0.05)。
2.免疫组化结果显示,ERβ在STC患者及对照组乙状结肠粘膜层、肌间神经丛及粘膜下神经丛都有表达,环肌层及纵肌层未见表达。与对照组相比,STC患者乙状结肠粘膜层、肌间神经丛及粘膜下神经丛ERβ表达均明显减少(p<0.01)。
3.RT-PCR结果显示,STC患者及对照组乙状结肠均表达ERβ1、ERβ2、ERβ5 mRNA,而ERβ3、ERβ4 mRNA未见表达。与对照组比较,STC组ERβ1、ERβ2、ERβ5 mRNA表达显著降低(p<0.01)。Western blot结果显示,STC患者乙状结肠ERβ蛋白表达明显低于对照组(p<0.01)。
4.成功建立STC大鼠模型,电生理方法检测显示,STC大鼠结肠离体肌条慢波频率及振幅明显低于对照组(p<0.05)。
5.电化学发光法检测显示,STC大鼠血清促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E2)、孕酮(P)及睾酮(Testo)与对照组相比均无显著性差异(P>0.05),泌乳素(PRL)检测量太少,无意义。
6.RT-PCR结果显示,STC大鼠及对照组结肠均表达rERβ1、rERβ2 mRNA,而rERβ1δ3、rERβ2δ3及rERβ1δ4 mRNA均未见表达。与对照组相比,STC大鼠结肠rERβ1、rERβ2 mRNA表达均显著降低(p<0.01)。Western blot结果显示,STC大鼠结肠ERβ蛋白表达明显低于对照组(p<0.01)。
7.阻断ERβ信号通路,电生理检测发现大鼠在体及离体结肠肌电慢波频率及振幅均显著降低(p<0.05)。RT-PCR结果显示,实验组大鼠结肠c-kit mRNA表达显著降低(p<0.01)。Western blot结果显示,实验组大鼠结肠c-kit蛋白表达显著降低(p<0.01)。免疫组化结果显示,结肠ICC主要包括四个部分,即粘膜下环肌层表面ICC、环肌层ICC、肌间丛ICC和纵肌层ICC,实验组大鼠结肠各部分ICC均显著减少,残存的ICC突起变短、变钝。免疫荧光染色分析结果显示,实验组大鼠结肠粘膜下环肌层表面ICC、环肌层ICC、肌间丛ICC和纵肌层ICC阳性面积均显著减少,结肠环肌层和纵肌层ICC几乎消失。
结论:
1.STC患者及模型大鼠血清性激素与对照组均无明显差异。提示血清性激素与STC的发病无直接联系。
2.STC患者乙状结肠肌间及粘膜下神经丛ERβ表达较对照组均明显降低。提示肌间及粘膜下神经丛ERβ表达降低可能和STC发病有关。
3.STC患者及模型大鼠结肠ERβ蛋白及ERβ同分异构体mRNA表达较对照组均显著降低。提示STC发病与ERβ基因在转录和(或)翻译水平的异常表达有关。
4.ERβ表达异常可能通过影响c-kit信号通路进而影响ICC数量和形态,导致STC发病。
Background:
Slow transit constipation (STC) is a colonic motor disorder, which is characterized by measurably delayed movement of materials through the colon. Although abnormalities in the neuronal networks of the colon have been demonstrated in patients with STC, the aetiology of it remains unclear. The severity of its symptoms and the failure of the conservative therapy ultimately led to colectomy for some patients with STC.
Health surveys revealed that chronic constipation caused by slow transit is common in women with an F/M ratio of 9:1. The cause and mechanism responsible for this syndrome are unknown. Among the female hormones, estrogen is one of the most important female homones,it can have an indispensable effect on body with estrogen receptor (ER), ER have two kinds of recptors, ie, ERαand ERβ. Studies reported ERβis the major ER in colon.That is to say, ERβcan determine the effect of estrogen and its antagonist on colon. Previous studies in our laboratories have shown that the expression of ERβprotein decreased greatly in mucous layer of sigmoid colon of patients with STC though immunohistochemistry method, which indicated ERβwas related to the pathogenesis of STC.
Interstitial cells of Cajal (ICC) have been shown to be the pacemaker cells of the intestine and have been implied in the pathogenesis of a number of gastrointestinal motility dysfunction including idiopathic slow transit constipation. A major breakthrough in this field was the discovery that the tyrosine kinase receptor c-kit are critical in the normal development, maturation, and maintenance of phenotype of ICC, and ICC can be reliably identified by c-kit immunohistochemical technique. Blockade of c-kit with neutralized antibody could induce transdifferentiation of ICC to a smooth muscle phenotype, and intestinal slow waves disappear. A loss-of-function mutation of c-kit results in depletion of stem cells and ICC, while its gain-of-function mutation results in their oncogenesis. Several studies indicate that ICC decreased in the colon of patients with STC, and the expression of c-kit mRNA was also reduced. So, abnormal expression of c-kit gene may disturb the SCF/c-kit signal pathway, and contribute to the alteration of ICC in STC. However, the mechanism is unknown.
Recent study suggested the blockade of ER signaling can lead to the decreased expression of c-kit mRNA, and ER may regulate c-kit signal pathway. So, we want to investigate further the expression of ERβin patients and rats with STC in transcription or translation phase. we study the changes of c-kit and ICC though blocking the ERβsignal pathway, and explore whether ERβhas any effects on ICC.
Objective: The aims of this study were:
(1) To investigate the sexual homones in patients and rats with STC, and to determine if sexual homones are abnormal.
(1) To detect the expression of ERβprotein and its isoform mRNA within the colon of patients and rats with STC, and to determine if the expression of ERβare abnormal.
(2) To explore the motility of rat colon though blocking the ERβsignal pathway, and further to investigate the expression of c-kit and ICC in the colon of experimental group, and to determine whether ERβhas any effects on ICC.
Methods:
Twenty patients with STC and Twenty age-matched controls were studied. The sexual homones were detected by Chemiluminescence. The distribution and expression of ERβwere observed with immunohistochemistry. Western blotting and Revers-transcriptional polymerase chain reaction (RT-PCR) technique were employed to determine the expression of ERβprotein and ERβisoform mRNA. An experimental rat model of STC was established with Rhubarb. Chemiluminescence was used to detect sexual homones. Frequency and amplitude of colonic slow waves were examined though electrophysiology. Western blotting and RT-PCR technique were employed to investigate the expression of ERβprotein and ERβisoform mRNA. Though blocking ERβpathway with tamoxifen (TAM), frequency and amplitude of colonic slow waves were examined though electrophysiology in both groups. Western blotting and RT-PCR technique were employed to determine the expression of c-kit protein and c-kit mRNA. The distribution and configuration of ICC were observed with immunohistochemistry. With an immunofluorescence staining, ICC were examined with fluorescence microscope and the area occupied by ICC were calculated with an image analysis system.
Results:
(1) Chemiluminescence displayed that FSH, LH, E2, PRL, P and Testo in patients with STC had no differences with that of control group (P>0.05).
(2) Immunohistochemistry displayed that ERβwas detected in mucous layer, myenteric nerve plexus and submucous nerve plexus, but not detected in muscular layer in the sigmoid colon of patients with STC and the controls. ERβwas mainly expressed in cytoplasm. The expression of ERβin each of the three regions in STC group decreased significantly compared with the control group (P<0.05).
(3) The RT-PCR results indicated that the ERβ1, ERβ2 and ERβ5 mRNA were detected in the sigmoid colon of patients with STC and the controls, but ERβ3 and ERβ4 mRNA were not detected. In comparison with the control group, the expression of ERβprotein and ERβ1, ERβ2 and ERβ5 mRNA of STC group significantly declined (P<0.01).
(4) Western blotting technique showed that ERβprotein reduced markedly in the sigmoid colon of patients with STC compared with the controls (P<0.01).
(5) An experimental rat model of STC was established with Rhubarb for 3 months. The frequency and amplitude of colonic slow waves were decreased in vitro (P<0.05).
(6) Chemiluminescence displayed that FSH, E2, LH, P and Testo in rats with STC had no differences with that of control group (P>0.05), and PRL was too little to be detected.
(7) The RT-PCR results indicated that the rERβ1 and rERβ2 mRNA were detected in the two groups,but rERβ1δ3, rERβ2δ3 and rERβ1δ4 mRNA were not detected. In comparison with the control group, the expression of rERβ1 and rERβ2 mRNA in the colon of rats with STC significantly declined (P<0.01).
(8) Western blotting technique showed that ERβprotein in the colon of rats with STC reduced markedly compared with the controls (P<0.01).
(9) Though blocking the ERβsignal pathway with TAM, the frequency and amplitude of slow waves of the experimental group were reduced significantly in vitro and in vivo compared with the control group(P<0.05). The RT-PCR and Western blot results indicated that the expression of c-kit mRNA and c-kit protein also decreased significantly (P<0.01). Immunohistochemistry displayed that ICC were located in the four regions (ICC-LM, ICC-MP, ICC-CM, ICC-SMB), and ICC in the experimental group appeared blunted and shorter compared with the controls. Immunofluorescence staining showed that the percentage of the area occupied by ICC in SMB, MP regions were significantly decreased while compared with the controls (p<0.01), and ICC in CM and LM regions almost can not be find.
Conclusions:
(1) Our studies revealed the sexual homones in patients and rats with STC had no differences with that in controls, which indicated that the serum sexual homones level had no direct relationship with STC.
(2) The reduction of ERβin myenteric nerve plexus and submucous nerve plexus may relate to the pathogenesis of STC.
(3) Abnormal expression of ERβgene in the colon of patients and rats with STC at transcription or translation phase may relate to the pathogenesis of STC.
(4) Abnormal expression of ERβgene may disturb the c-kit signal pathway, and contribute to the alteration of ICC.
引文
1. Bharucha AE, Phillips SF. Slow transit constipation [J]. Gastroenterol Clin North Am, 2001, 30(1):77-95.
2. Wald A. Slow Transit Constipation [J]. Curr Treat Options Gastroenterol, 2002, 5(4): 279-283.
3. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and management [J]. Colorectal Dis, 2003, 5(4), 288-296.
4. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectal biopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8(12):1207-1211.
5. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3):143-150.
6. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48):1540-1544.
7. Porter AJ, Wattchow DA, Hunter A, et al. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation [J]. Int J Colorectal Dis, 1998, 13(5-6):208-216.
8.童卫东,刘宝华,张胜本,等.顽固性慢传输性便秘的外科处理及病因研究[J].中华胃肠外科杂志, 2002, 5(4): 266-268.
9. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation [J]. Gastroenterology, 2005, 128(3): 667-675.
10. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J]. Cancer res, 2000, 60(2): 245-248.
11. Torihashi S, Fujimoto T, Trost C, et al. Calcium oscillation linked to pacemaking of interstitial cells of Cajal[J]. J Biol Chem, 2002, 277(21):19191-19197.
12. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
13. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes[J]. Gastroenterology, 2001, 121(2):427-434.
14. Tong WD, Liu BH, Zhang LY, et al. Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis. 2004,19:467-473.
15. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
16. Torihashi S, Nishi K, Tokutomi Y, et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype[J]. Gastroenterology, 1999, 117(1):140-148.
17. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation [J]. Int J Colorectal Dis. 2005, 20: 363-367.
18.韩炜,李学会,李延青,等.肠粘膜雌孕激素受体表达在肠易激综合征发病机制中的作用研究[J].胃肠病学和肝病学杂志, 2002, 11(4):332-334.
19.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12):1246-1248.
20. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
1. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis, 2005,20 (4):363-367.
2. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48): 1540-1544.
3. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G protein levels in female chronic constipation[J].Gastroenterology, 2005,128(3): 667 -675.
4.张吉强,蔡文琴.雌激素β受体研究进展[J].生理科学进展, 2001, 32(1): 68-70.
5. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J]. Cancer res, 2000, 60(2): 245-248.
6. Bharucha AE, Wald A, Enck P, et al. Functional anorectal disorders. Gastroenterology, 2006, 130: 1510-1518.
7.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12): 1246-1248.
8. Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA[J]. Science, 1986, 231:1150-1154.
9. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel estrogen receptors expressed in rat prostate and ovary [J]. Proc Natl Acad Sci USA, 1996, 93(12): 5925-5930.
10. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor [J]. FEBS Lett, 1996, 392(1):49-53.
11. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and Characterization of Human Estrogen Receptorβisoforms[J]. Biochem Biophys Res Commun, 1998, 247:75-78.
12. Poola, I, Abraham, J, Baldwin, K, et al. Estrogen Receptors Beta 4 and Beta 5 Are Full Length Functionally Distinct ERβIsoforms. Endocrine, 2005, 27:227-238.
13. Yuet-Kin Leung, Paul Mak, Sazzad Hassan, et al. Estrogen receptor ERβisoforms: A key to understanding ERβsignaling[J]. PNAS, 2006, 103(35):13162-13167.
14. Enmark E, Pelto-Huikko M., Grandien K, et al. Human Estrogen Receptor b-Gene Structure, Chromosomal Localization, and Expression Pattern [J]. J Clin Endocrinol Metab, 1997, 82(12):4258-4265.
15. Aytug N, Giral A, Imeryuz N, et al. Gender influence on jejunal migrating motor complex[J].Am J Physiol 2002, 280:G255-263.
16. Gill RC,Bowes KL,Kingma YJ. Effect of progesterone on canine colonic smooth muscle[J]. Gastroenterology, 1985, 88(6):1941-1947.
17.童卫东,刘宝华,张胜本.顽固性慢传输便秘的外科治疗及病因研究[J].中华胃肠外科杂志, 2002, 5(4):266-268.
18. Kamm MA, Farthing MJ, Lennard-Jones JE, et al. Steroid hormone abnormalities in women with severeid iopathic constipation[J]. Gut, 1991, 32(1):80-84.
19. Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in post menopausal women[J]. Neurogastroenterol & Motil, 2006, 18(10):911-918.
20.韩炜,李学会,李延青,等.肠粘膜雌孕激素受体表达在肠易激综合征发病机制中的作用研究[J].胃肠病学和肝病学杂志, 2002, 11(4): 332-334.
21. Campell-Thompson M, Jeanette L, Bhavna B. Expression of Estrogen Receptor (ER) subtyes and Isoform in Colon Cancer[J]. Cancer research, 2001, 61(15): 632-640.
22. Tomita R, Fujisaki S, Ikeda T, et al. Role of nitric oxide in the colon of patients with slow transit constipation [J]. Dis Colon Rectum, 2002, 45:593-600.
23.陈小武,祝善乐,范玉华,等.雌激素对卵巢摘除大鼠心内神经节细胞胆碱乙酰基转移酶和一氧化氮合酶表达的影响[J].解剖学杂志, 2004, 27(4):408-410.
24. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation [J]. Gut, 2002, 51 (4): 496-501.
25. Kitamura Y, Hirota S, Nishida T. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis [J]. Mutat Res, 2001, 477(1-2):165-171.
26. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
1.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
2.李业鹏,崔生辉,江涛,等.小鼠便秘模型的建立[J].中国食品卫生杂志, 2002, 12(1): 1-4.
3.万锦洲,马锦星,刘卉.一种简易的小鼠便秘模型[J].中国药理学通报, 1994, 10(1): 71-72.
4. Shimotoyodome A,Meguro S,Hase T, et al.Decreased colonic mucus in rats with loperamide induced constipation [J]. Comp-Biochem-Physiol-A-Mol-Integr-Physiol, 2000, 126(2): 203-212.
5. Stelzner F, Hansen H. Pathophysiology of chronic constipation and new therapy recommendation [J]. Zentralbl Chir, 1999, 124(9):804-811.
6. Smith B. Effect of irritant purgatives on the muenteric plexus in man and mouse[J]. Gut, 1986, 9:139-143.
7. Park HJ, Kamm MA. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation [J]. Dis Colon Rectum, 1995, 38(5):509-513.
8. Cavallini G, Filippini M, Bovo P, et al. Medical therapy of chronic idiopathic constipation[J]. Chir Ital, 1993, 45(1~6):3-28.
9.刘宝华,孟健,张连阳,等.乙酰胆碱和异丙肾上腺素在慢传输性便秘发生中的作用[J].第三军医大学学报, 2004, 26 (12):1045-1048.
10.孟健,刘宝华,郑仲谨.大鼠“泻剂结肠”模型的动力学研究[J].重庆医学, 2003,32(3):332-333.
11.黄显凯,胥基太,童卫东.“泻剂结肠”大鼠结肠肌电活动及其对乙酰胆碱反应的变化[J].第三军医大学学报, 2003, 25 (11):997-999.
12.张连阳,高峰,童卫东,等.大鼠泻剂结肠模型的建立[J].华人消化杂志, 1998, 6(10):864-866.
13. Seidel SA, Hegde SS, Bradshaw LA, et al. Intestinal tachyarrhythmias during small bowel ishchemia [J]. AM J Physiol, 1999, 277(5Pt1):G993-999.
14.张经济,连至诚.消化道生理及病理生理学[M].广州:广东科技出版社,1997, 1041-1106.
15. Ahmed S, Ali S. Electric activity spreads in the colonic longitudinal but not the circular musculature: Role in colonic motility[J]. Front Biosci, 2000, 5:5-8.
16. Shafik A, El-Sibai O, Mostafa RM, et al. Study of the mechanism of rectal motility: the mass squeeze contraction [J]. Arch Physiol Biochem, 2001, 109(5):418-423.
17.潘国宗,曹世植.肠道运动生理和检查方法,现代胃肠病学[M].第11版.北京:人民卫生出版社, 1994:1077.
18. Shafik A, El-Sibai O, Shafik AA, et al. Electric activity of the colon in irritable bowel syndrome: the tachyarrhythmic electric pattern [J]. J Gastroenterol Hepatol, 2004, 19(2): 205-210.
19.张永斌,邹移海,连至诚,等.溃疡性结肠炎大鼠模型及其结肠电异常[J].实验动物科学与管理, 2002,19(2):5-7.
20. Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene [J]. Mol Cell Endocrinol, 1997, 132:195-199.
21. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al. A novel isform of estrogen receptor beta with 18 amino acid insertion in the ligand binding dominant negative regulator of estrogen action [J].Biophys Res Commun, 1998, 246:142-147.
22. Petersen DN, Tkalcevic GT, Koza-Taylor PH, et al. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed innormal rat tissues [J]. Endocrinology, 1998, 139:1082-1092.
23. Price Jr RH, Lorenzon N, Handa RJ. Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variant missing exon 4[J]. Brain Res Mol, 2000, 80:260-268.
24. George G, Kuiper JM, Carlsson BO, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptorsαandβ[J]. Endocrinology, 1997, 138: 863-870.
25. Campbell-Thompson M. Estrogen Receptor a and b Expression in Gastrointestinal Tract with Regulation of Trefoil Factor Family 2 mRNA Levels in Ovariectomized Rats[J]. Biochemical and biophysical research communications, 1997, 240: 478-483.
1. Torihashi S, Fujimoto T, Trost C, et al. Calcium oscillation linked to pacemaking of interstitial cells of Cajal[J]. J Biol Chem, 2002, 277(21):19191-19197.
2. Sanders KM, Ordog T, Ward SM, et al. Physiology and pathophysiology of the interstitial cells of cajal: from bench to bedside IV [J]. Am J Physiol Gastrointest Liver Physiol, 2002, 282(5): G747-G756.
3. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation[J]. Gut, 2002, 51(4):496-501.
4. Wang XY, Vannucchi MG, Nieuwmeyer F, et al. Changes in interstitial cells of Cajal at the deep muscular plexus are associated with loss of distention induced burst-type muscle activity in mice infected by Trichinella spiralis[J]. Am J Pathol, 2005, 167: 437-453.
5. Ward SM, Sanders KM. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside I. Functional development and plasticity of interstitial cells of Cajal networks [J]. Am J Physiol Gastrointest Liver Physiol, 2001, 281(3):G602-611.
6. Sanders KM, Ordog T, Koh SD, et al. Development and plasticity of interstitial cells of Cajal[J]. Neurogastroenterol Motil, 1999, 11(5):311-338.
7. Kitamura Y, Hirota S, Nishida T. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis [J]. Mutat Res, 2001, 477(1-2):165-171.
8.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
9. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
10. Campbell-Thompson M. Estrogen receptor a and b expression in gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats [J]. Biochemical and biophysical research communications, 1997, 240:478-483.
11. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectalbiopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8(12):1207-1211.
12. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3):143-150.
13. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48): 1540-1544.
14. Porter AJ, Wattchow DA, Hunter A, et al. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation[J]. Int J Colorectal Dis, 1998, 13(5-6):208-216.
15.童卫东,刘宝华,张胜本,等.顽固性慢传输性便秘的外科处理及病因研究[J].中华胃肠外科杂志, 2002, 5(4): 266-268.
16.童卫东,蔡文琴,张胜本. Cajal间质细胞研究进展[J].解剖科学进展, 1997, 3(2): 116-120.
17. Huizinga JD, Thuneberg L, Kluppel M, et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J]. Nature, 1995, 373(6512):347-349.
18. Rich A, Hanani M, Ermilov LG, et al. Physiological study of interstitial cells of Cajal identified by vital staining[J]. Neurogastroenterol Motil, 2002, 14(2):189-196.
19. Epperson A, Hatton WJ, Callaghan B, et al. Molecular markers expressed in cultured and freshly isolated interstitial cells of Cajal[J]. Am J Physiol Cell Physiol, 2000, 279(2): C529-539.
20. Burnstock G, Lavin S. Interstitial cells of Cajal and purinergic signalling[J]. Auton Neurosci, 2002, 97(1):68-72.
21. Nakahara M, Isozaki K, Hirota S, et al. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus[J]. J Gastroenterol Hepatol, 2002, 17(6):666-670.
22. Porcher C, Baldo M, Henry M, et al. Deficiency of interstitial cells of Cajal in the small intestine of patients with Crohn's disease[J]. Am J Gastroenterol, 2002, 97(1):118-125.
23. Rolle U, Piotrowska AP, Nemeth L, et al. Altered distribution of interstitial cells of Cajal in Hirschsprung disease[J]. Arch Pathol Lab Med, 2002, 126(8):928-933.
24. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
25. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitoryinnervation in insulin-dependent diabetes[J]. Gastroenterology, 2001, 121(2):427-434.
26. Tong WD, Liu BH, Zhang LY, et al. Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis. 2004, 19: 467-473.
27. Isozaki K, Hirota S, Miyagawa J, et al. Deficiency of c-kit cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction[J]. Am J Gastroenterol, 1997, 92(2):332-334.
28. Rich A, Miller SM, Gibbons SJ, et al. Local presentation of Steel factor increases expression of c-kit immunoreactive interstitial cells of Cajal in culture. Am J Physiol Gastrointest Liver Physiol [J], 2003, 284(2):G313-320.
29. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation [J]. Int J Colorectal Dis. 2005, 20: 363-367.
30. KrausWL, Mcinerney EM, Katzenellenbogen BS. Ligand-dependent tanscriptionally productive association of the amino-and carboxyterminal regions of a steroid hormone nuclear receptor [J]. Proc Natl Acad Sci USA, 1995, 92(12):314-318.
31. Mcinerney EM, Tsai MJ, O’Malley BW, et al. Analysis of estrogen receptor transcriptional enhancement by a nuclear receptor coactivator[J]. Proc Natl Acad Sci USA, 1996, 93(10): 069-073.
32. Cowley SM, Parker MG. A comparison of transcriptional activation by ER alpha and ER beta [J]. J Steroid Biochem Mol Biol, 1999, 69:165-175.
33. Barkhem T, Carlsson B, Nilsson Y, et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists[J]. Mol Pharmacol, 1998, 54:105-112.
34. Giaroni C, De Ponti F, Cosentino M, et al. Plasticity of the enteric nervous system[J]. Gastroenterology, 1999, 117:1438-1458.
35. Hanani M, Ledder O, Yutkin V, et al. Regeneration of myenteric plexus in the mouse colon after experimental denervation with benzalkonium chloride[J]. J Comp Neurol, 2003, 462:315-327.
36. Chang IY, Glasgow NJ, Takayama I, et al. Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction[J]. J Physiol (Lond).2001, 536:555-568.
1. Warner M, Nilsson S, Gustafsson JA. The estrogen receptor family[J]. Curr Opin Obs Gyn, 1999, 11 (3):249-254.
2. Gupta RR, Sen S, Diepenhorst LL, et al.Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats [J]. Brain Res, 2001, 888(2):356-365.
3. Ogawa, S, Chester AE, Hewitt SC, et al. Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO)[J]. Proc. Natl Acad Sci USA, 2000, 97( 26):14737-14741.
4. Hilakivi-Clarke L. Estrogens, BRCA1, and breast cancer[J]. Cancer Res, 2000, 60(18): 4993-5001.
5. Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA[J]. Science, 1986, 231:1150-1154.
6. Kuiper GG, Enmark E, Pelto-Huikko M, et al.Cloning of a novel estrogen receptors expressed in rat prostate and ovary[J]. Proc Natl Acad Sci USA, 1996, 93(12): 5925-5930.
7. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor[J]. FEBS Lett, 1996, 392(1):49-53.
8. Murphy LC, Dotzlaw H, Leygue E,et al. Estrogen receptor variants and mutations: a review[J]. J Steroid Biochem Mol Biol,1997, 62:363-372.
9. Poola I, Koduri S, Chatra S.et al. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targetedprimer approach [J]. J Steroid Biochem Mol Biol, 2000, 72(5):249-258.
10. Enmark E, Pelto-Huikko M, Grandien K, et al. Human Estrogen Receptor b-Gene Structure, Chromosomal Localization, and Expression Pattern[J]. J Clin Endocrinol Metab, 1997, 82(12):4258-4265.
11. Giguere V, Tremblay A, Tremblay GB. Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling [J]. Steroids, 1998, 63(5-6): 335-339.
12. Ogawa S, Inoue S, Watanabe T, et al. The Complete Primary Structure of Human Estrogen Receptor b (hERb) and its Heterodimerization with ERa in Vivo and in Vitro[J]. Biochem Biophys Res Commun, 1998, 243:122-126.
13. Dupont S, Krust A, Gansmuller A, et al. Effect of single and compound knockouts of estrogen receptors alpha (ER alpha) and beta (ER beta) on mouse reproductive phenotypes[J]. Development, 2000, 127:4277-4291.
14. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and Characterization of Human Estrogen Receptorβisoforms[J].Biochem Biophys Res Commun, 1998, 247:75-78.
15. Poola, I, Abraham, J, Baldwin, K, et al. Estrogen Receptors Beta 4 and Beta 5 Are Full Length Functionally Distinct ERβIsoforms [J]. Endocrine, 2005, 27:227-238.
16. Yuet-Kin Leung, Paul Mak, Sazzad Hassan, et al. Estrogen receptor ERβisoforms: A key to understanding ERβsignaling [J]. PNAS, 2006, 103(35):13162-13167.
17. Ogawa S,Inoue S, Watanabe T, et al. Molecular cloning and characterization of human estrogen. receptorβcx: a potential inhibitor of estrogen action in human[J]. Nucleic Acids Res, 1998, 6(15): 3505-3512.
18. Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene [J]. Mol Cell Endocrinol, 1997, 32:195-199.
19. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al.A novel isform of estrogen receptor beta with 18 amino acid insertion in the ligand binding dominant negative regulator of estrogen action,Biophys[J]. Res Commun, 1998, 246:142-147.
20. Petersen DN, Tkalcevic GT, Koza-Taylor PH, et al. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed innormal rat tissues [J]. Endocrinology,1998, 139:1082-1092.
21. Price Jr RH, Lorenzon N, Handa RJ. Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variantmissing exon 4[J]. Brain Res Mol Brain Res, 2000, 80:260-268.
22. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action [J]. Biochem Biophys Res Commun, 1998, 246:142-147.
23. George G, Kuiper JM, Carlsson BO, et al.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptorsαandβ[J]. Endocrinology, 1997, 138:863-870.
24. Fuqua SA, Schiff R, Parra I, et al. Expression of wild type estrogen receptor beta and variant isoforms in human breast cancer [J].Cancer Res, 1999, 59: (21) 5425-5428.
25. Iwao K, Miyoshi Y, Egawa C, et al. Quantitative analysis of estrogen receptor alpha and beta messenger RNA expression in breastcarcinoma by real-time polymerase chain reaction [J]. Cancer, 2000, 89 (8):1732-1738.
26. Leygue E, Dotzlaw H, Watson PH, et al. Expression of estrogenreceptor beta1 , beta2 , and beta5 messenger RNAs in human breast tissue[J].Cancer Res,1999,59(6): 1175-1179.
27. Campell-Thompson M, Jeanette L, Bhavna B. Expression of Estrogen Receptor (ER) subtyes and Isoform in Colon Cancer[J]. cancer research, 2001, 61(15): 632-640.
28. Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor beta in the brain: from form to function [J]. Brain Res Rev, 2007, 37:223-234.
29. Campbell-Thompson M. Estrogen receptor a and b expression in gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats [J]. Biochem Biophys Res Commun, 1997, 240:478-483.
30. Dardes RC, Jordan VC. Novel Agents to modulate oestrogen action[J]. Br Med Bull, 2000, 56 (3):773-786.
31. Fiorelli G, Picariello L, Martineti V, et al. Estrogen synthesis in human colon cancer epithelial cells [J]. J Steroid Biochem Mol Biol, 1999, 71 (526):223-230.
32. Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to anti apoptosis in breast cancer [J]. Mol Endocrinol, 2000, 14:1434-1447.
33. Kousteni S, Bellido T, Plotkin LI, et al. Nongeno-tropic, sex-nonspecific signaling through the estrogen or androgenreceptors: dissociation from transcriptional activity [J].Cell, 2001, 104: 719-730.
34. Razandi M, Pedram A, Greene GL, et al. Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERa and ERb expressed in CHO cells [J]. Mol Endocrinol, 1999, 13: 307-319.
35. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase[J]. Nature, 2000, 407:538-541.
36. Witte D, Chirala III, Younes A, et a1.Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Human Pathol, 2001, 32(9): 940-944.
37.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12): 1246-1248.
38. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J ]. Cancer res, 2000, 60(2): 245-248.
39. Konstantinopoulos PA, Kominea A,Vandoros G, et al. Oestrogen receptor beta ( ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation[J]. Eur J Cancer, 2003, 39 (9):1251-1258.
40. Fiorelli G, Picariello L, Martinet V, et al. Functional estrogen receptorβin colon cancer cells.Biochem.Biophys[J].Res.Commun, 1999, 261(2): 521-527.
41. Arai N, Strom A, Rafter J, et a1. Estrogen receptorβmRNA in colon cancer cells: growth effects of estrogen and genistein[J]. Biochem Biophys Res Common, 2000, 270(2):425-431.
1. Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psycho- logical enquiry. Eur J Gastroenterol Hepatol [J], 2001,13(1):39-44.
2. Chattat R, Bazzocchi G, Balloni M, et al. Illness behavior , affective disturbance and intestinal transit time in idiopathic constipation[J].J Psychosom Res, 1997,42 (1): 95-100.
3. Emmanuel AV, Mason HJ, Kamm MA. Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder [J]. Gut, 2001, 49(3):209-213.
4.徐海珊,姜铀,战敏,等.慢性特发性便秘患者肛门直肠动力及精神心理因素的研究[J].临床内科杂志, 2001,18(9): 379-381.
5.刘海峰,何俊堂.慢传输便秘发病机制的研究进展.胃肠病学[J].2005, 10(6):379-381.
6. Vannucchi MG. Receptors in interstitial cells of Cajal: Idendification and possible p hysiological roles[J]. Microsc Res Tech,1999,47:325-335.
7. He CL, Burgart L, Wang L , et al. Decreased interstitial cell of cajal volume in patients with slow transit constipation[J]. Gastroenterology, 2000, 118(1):14-21.
8. Lyford GL, He CL, Softer E, et al. Pancolonic decrease in interstitial cells of Cajal in patients with slow transit constipation[J]. Gut, 2002, 51(4):496-501.
9. Wedel T, Spiegler J, Soetlner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow transit constipation and megaeolon. Gastroenterology [J], 2002, 123(5):1459-1467.
10. Torihashi S, Nishi K, Tokutomi Y, et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype [J]. Gastroenterology, 1999, 117(1):140-148.
11. Chang IY, Glasgow NJ, Takayama I, et al. Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction [J].J Physiol, 2001, 536:555-568.
12. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48):1540-1544.
13. Schouten WR, ten Kate FJ, de Graaf EJ, et al. Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament [J] .Dis Colon Rectum, 1993, 36(12):1112-1117.
14.张胜本,黄显凯,张连阳,等. 17例慢传输性便秘外科治疗分析[J].中华外科杂志.1999, 37(2):91-92.
15. Wedel T, Roblick UJ, Ott V, et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow transit constipation[J]. Dis Colon Rectum, 2002, 45(1):54-62.
16. Bassotti G, Villanacci V, Maurer CA, et al. The role of glial cells and apoptosis of enteric neurons in the neuropathology of intractable slow transit constipation[J]. Gut, 2006, 55:41-46.
17. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectal biopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8 (12):1207-1211.
18. Tomita R, Fujisaki S, Ikeda T, et al. Role of nitric oxide in the colon of patients with slow- transit constipation[ J]. Dis Colon Rectum, 2002, 45 (5):593-600.
19. Zhao RH, Baig MK, Mack J, et al. Alteredserotonin immunoreactivities in the left colon of patients with colonic inertia [J]. Colorectal Dis, 2002, 4 (1):56-60.
20. Zhao RH, Baig MK, Thaler KJ, et al.Reduced expression of serotonin receptor(s) in the left colon of patients with colonic inertia [J] . Dis Colon Rectum, 2003, 46(1): 81-86.
21. Ding JH, Fu CG, Zhao RH, et al. Serotonin transporter gene polymorphism in slow transit constipation [J]. Chinese Journal of Gastrointestinal Surgery, 2006, 9(4):328- 330.
22. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopnthic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3): 143-150.
23. Krogh K, Mosdal C, Laurberg S. Gastrointestinal and segmental colonic transit times in patients with acute and chronic spinal cord lesions [J]. Spinal Cord, 2000, 38(10): 615-621.
24. Chia YW, Lee TKY, Kour NWet al. Microchip implants on the anterior sacral roots in patients with spinal trauma: does it improve bowel function[J]. Dis Colon Rectum, 1996, 39 (6):690-694.
25. Speakman CTM, Madden MV, Nicholls RJ, et al. Lateral ligament division during rectopexy causes constipation but prevents recurrenceresults of a prospective randomised study[J]. Br J Surg, 1991, 78:1431-1433.
26. Dan J HV, Gosselink MJ, Drogendijk AC, et al. Changes in bowelfunction after hysterectomy[ J]. Dis Colon Rectum, 1997, 40 (11):1342-1346.
27. Slater BJ, Varma JS, Gillespie JI. Abnormalities in the contractile properties of colonic smooth muscle in idiopathic slow transit constipation[J]. Br J Surg, 1997, 84(2): 181-184.
28. Park H J, Kamm MA, Abbasi AM, et al. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation[J]. Dis Colon Rectum, 1995, 38(5):509-513.
29. Knowles CH, Nickols CD, Scott SM, et al. Smooth muscle inclusion bodies in slow transit constipation [J]. J Pathol, 2001, 193(3):390-397.
30. Dufour P, Gendre P. Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration [J]. Gut, 1984, 25(12):1358-1363.
31. Tzavella K, Schenkirsch G, Riepl RL, et al. Effects of long term treatment withanthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon [J]. Eur J Gastroenterol Hepatol, 1995, 7(1): 13-20.
32.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
33. Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement[J]. Gastroenterology, 1997, 112:1366-1371.
34. Howe S, Eaker EY, Sallustio JE, et al. Antimyenteric neuronal antibodies inscleroderma [J]. J Clin Invest, 1994, 94:761-770.
35. Basilisco G, Barbera R, Vanoli M, et al. Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis[J]. Dig Dis Sci, 1993, 38: 1525-1529.
36. Lindberg G, Glia A, Nyberg B, et al. Lymphocytic Epithelioganglionitis-A new entity causing severe motility disorders of the gut[J]. Gastroenterology, 1999, 116:4476.
37. Smith VV, Milla PJ. Histological phenotypes of enteric smooth muscle disease causingfunctional intestinal obstruction in childhood[J]. Histopathology, 1997, 31: 112-122.
38. Peracchi M, Basilisco G, Tagliabue R, et al. Postprandial gut peptide plasma levels inwomen with idiopathic slow-transit constipation[J]. Scand-J-Gastroenterol, 1999, 34(1):25-28.
39. Penning C, Delemarre JB, Bemelman WA, et al.A Proximal and distal gut hormone secretion in slow transit constipation[J]. Eur-J-Clin-Invest, 2000, 30(8): 709-714.
40. Vander Sijp JR, Kamm MA, Nightingale JM, et al. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation[J]. Am J Gastroenterol, 1998, 93:1351-1356.
41. Enerson GT. Gastrointestinal motility in pregnancy[J]. Gastroenterrol Clin-North-Am, 1992, 21:751-776.
42. Jung HK, Kim DY, Moon IH. Effects of gender and menstrual cycle on colonict ransit time in Gastrointestinal motility in pregnancy[J]. Korean J Intern Med, 2003, 18(3): 181-186.
43. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy [J]. Ann Intern Med, 1993, 118(5):366-375.
44. Aytug N, Giral A, Imeryuz N, et al. Gender influence on jejunal migrating motor complex[J].Am J Physiol 2002, 280:G255-263.
45. Gill RC,Bowes KL,Kingma YJ. Effect of progesterone on canine colonic smooth muscle[J]. Gastroenterology, 1985, 88(6):1941-1947.
46.童卫东,刘宝华,张胜本.顽固性慢传输便秘的外科治疗及病因研究[J].中华胃肠外科杂志, 2002, 5(4):266-268.
47. Kamm MA, Farthing MJ, Lennard-Jones JE, et al. Steroid hormone abnormalities in women with severeid iopathic constipation[J]. Gut, 1991, 32(1):80-84.
48. Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy[J]. Am J Physiol, 1986, 251:G46-50.
49. Bielefeldt K, Waite L, Abboud FM, et al. Nongenomic effects of progesterone on human intestinal smooth muscle cells[J]. Am J Physiol, 1996, 271:G3702-3706.
50. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G-protein levels infemale chronic constipation [J]. Gastroenterology, 2005, 128(3): 667-675.
51. Gonenne J, Esfandyari T, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women [J]. Neurogastr-oenterol-Motil, 2006, 18(10):911-918.
52.尹淑慧.水通道与大肠内液体转运及便秘的关系[J].国际病理科学与临床杂志, 2005, 25(4):364-367.
53. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and Management [J]. Colorectal Dis, 2003, 5(4):288-296.
54. Ferguson A, Culbert P, Gillett H, et al. New polyethylene glycol electrolyte solution for the treatment of constipation and faecal impaction [J]. Ital J Gastroenterol Hepatol, 1999, 31(3):249-252.
55. Wildt S, Norby Rasmussen S, Lysgard Madsen J, et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test [J]. Scand J Gastroenterol, 2003, 38(8):826-830.
56. Sauter GH, Moussavian AC, Meyer G, et al. Bowel habits and bile acid malabsorptionin the months after cholecystectomy[J]. Am J Gastroenterol, 2002, 97(7):1732-1735.
57.熊理守,陈昊湖,陈惠新,等.广东省社区人群慢性便秘的流行病学研究[J].中华消化杂志, 2004, 24(8):488-491.
58.尉秀清.广州市居民功能性便秘流行病学调查[J].胃肠病学和肝病学杂志, 2001, 10(2):150-151.
59.阚志超.天津市成年人慢性便秘调查及相关因素分析[J].中华消化杂志, 2004, 24(10):612-614.
60. Pashankar DS, Loening-Baucke V. Increased prevalence of obesity in children with functional constipation evaluated in an academic medical center [J]. Pediatrics, 2005, 116(3):377-380.
61. Nakaji S, Tokunaga S, Sakamoto J, et al. Relationship between lifestyle factors and defecation in a Japanese population[J]. Eur J Nutr, 2002, 41(6):244-248.
62. Voderholzer WA, Schatke W, MfihldoHer BE, et al. Clinical response to dietary fiber treatment of chronic constipation[J]. Am J Gastroenterol, 1997, 92:95-98.
2. Wald A. Slow Transit Constipation [J]. Curr Treat Options Gastroenterol, 2002, 5(4): 279-283.
3. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and management [J]. Colorectal Dis, 2003, 5(4), 288-296.
4. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectal biopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8(12):1207-1211.
5. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3):143-150.
6. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48):1540-1544.
7. Porter AJ, Wattchow DA, Hunter A, et al. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation [J]. Int J Colorectal Dis, 1998, 13(5-6):208-216.
8.童卫东,刘宝华,张胜本,等.顽固性慢传输性便秘的外科处理及病因研究[J].中华胃肠外科杂志, 2002, 5(4): 266-268.
9. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation [J]. Gastroenterology, 2005, 128(3): 667-675.
10. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J]. Cancer res, 2000, 60(2): 245-248.
11. Torihashi S, Fujimoto T, Trost C, et al. Calcium oscillation linked to pacemaking of interstitial cells of Cajal[J]. J Biol Chem, 2002, 277(21):19191-19197.
12. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
13. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes[J]. Gastroenterology, 2001, 121(2):427-434.
14. Tong WD, Liu BH, Zhang LY, et al. Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis. 2004,19:467-473.
15. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
16. Torihashi S, Nishi K, Tokutomi Y, et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype[J]. Gastroenterology, 1999, 117(1):140-148.
17. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation [J]. Int J Colorectal Dis. 2005, 20: 363-367.
18.韩炜,李学会,李延青,等.肠粘膜雌孕激素受体表达在肠易激综合征发病机制中的作用研究[J].胃肠病学和肝病学杂志, 2002, 11(4):332-334.
19.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12):1246-1248.
20. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
1. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis, 2005,20 (4):363-367.
2. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48): 1540-1544.
3. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G protein levels in female chronic constipation[J].Gastroenterology, 2005,128(3): 667 -675.
4.张吉强,蔡文琴.雌激素β受体研究进展[J].生理科学进展, 2001, 32(1): 68-70.
5. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J]. Cancer res, 2000, 60(2): 245-248.
6. Bharucha AE, Wald A, Enck P, et al. Functional anorectal disorders. Gastroenterology, 2006, 130: 1510-1518.
7.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12): 1246-1248.
8. Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA[J]. Science, 1986, 231:1150-1154.
9. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel estrogen receptors expressed in rat prostate and ovary [J]. Proc Natl Acad Sci USA, 1996, 93(12): 5925-5930.
10. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor [J]. FEBS Lett, 1996, 392(1):49-53.
11. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and Characterization of Human Estrogen Receptorβisoforms[J]. Biochem Biophys Res Commun, 1998, 247:75-78.
12. Poola, I, Abraham, J, Baldwin, K, et al. Estrogen Receptors Beta 4 and Beta 5 Are Full Length Functionally Distinct ERβIsoforms. Endocrine, 2005, 27:227-238.
13. Yuet-Kin Leung, Paul Mak, Sazzad Hassan, et al. Estrogen receptor ERβisoforms: A key to understanding ERβsignaling[J]. PNAS, 2006, 103(35):13162-13167.
14. Enmark E, Pelto-Huikko M., Grandien K, et al. Human Estrogen Receptor b-Gene Structure, Chromosomal Localization, and Expression Pattern [J]. J Clin Endocrinol Metab, 1997, 82(12):4258-4265.
15. Aytug N, Giral A, Imeryuz N, et al. Gender influence on jejunal migrating motor complex[J].Am J Physiol 2002, 280:G255-263.
16. Gill RC,Bowes KL,Kingma YJ. Effect of progesterone on canine colonic smooth muscle[J]. Gastroenterology, 1985, 88(6):1941-1947.
17.童卫东,刘宝华,张胜本.顽固性慢传输便秘的外科治疗及病因研究[J].中华胃肠外科杂志, 2002, 5(4):266-268.
18. Kamm MA, Farthing MJ, Lennard-Jones JE, et al. Steroid hormone abnormalities in women with severeid iopathic constipation[J]. Gut, 1991, 32(1):80-84.
19. Gonenne J, Esfandyari T, Camilleri M, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in post menopausal women[J]. Neurogastroenterol & Motil, 2006, 18(10):911-918.
20.韩炜,李学会,李延青,等.肠粘膜雌孕激素受体表达在肠易激综合征发病机制中的作用研究[J].胃肠病学和肝病学杂志, 2002, 11(4): 332-334.
21. Campell-Thompson M, Jeanette L, Bhavna B. Expression of Estrogen Receptor (ER) subtyes and Isoform in Colon Cancer[J]. Cancer research, 2001, 61(15): 632-640.
22. Tomita R, Fujisaki S, Ikeda T, et al. Role of nitric oxide in the colon of patients with slow transit constipation [J]. Dis Colon Rectum, 2002, 45:593-600.
23.陈小武,祝善乐,范玉华,等.雌激素对卵巢摘除大鼠心内神经节细胞胆碱乙酰基转移酶和一氧化氮合酶表达的影响[J].解剖学杂志, 2004, 27(4):408-410.
24. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation [J]. Gut, 2002, 51 (4): 496-501.
25. Kitamura Y, Hirota S, Nishida T. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis [J]. Mutat Res, 2001, 477(1-2):165-171.
26. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
1.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
2.李业鹏,崔生辉,江涛,等.小鼠便秘模型的建立[J].中国食品卫生杂志, 2002, 12(1): 1-4.
3.万锦洲,马锦星,刘卉.一种简易的小鼠便秘模型[J].中国药理学通报, 1994, 10(1): 71-72.
4. Shimotoyodome A,Meguro S,Hase T, et al.Decreased colonic mucus in rats with loperamide induced constipation [J]. Comp-Biochem-Physiol-A-Mol-Integr-Physiol, 2000, 126(2): 203-212.
5. Stelzner F, Hansen H. Pathophysiology of chronic constipation and new therapy recommendation [J]. Zentralbl Chir, 1999, 124(9):804-811.
6. Smith B. Effect of irritant purgatives on the muenteric plexus in man and mouse[J]. Gut, 1986, 9:139-143.
7. Park HJ, Kamm MA. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation [J]. Dis Colon Rectum, 1995, 38(5):509-513.
8. Cavallini G, Filippini M, Bovo P, et al. Medical therapy of chronic idiopathic constipation[J]. Chir Ital, 1993, 45(1~6):3-28.
9.刘宝华,孟健,张连阳,等.乙酰胆碱和异丙肾上腺素在慢传输性便秘发生中的作用[J].第三军医大学学报, 2004, 26 (12):1045-1048.
10.孟健,刘宝华,郑仲谨.大鼠“泻剂结肠”模型的动力学研究[J].重庆医学, 2003,32(3):332-333.
11.黄显凯,胥基太,童卫东.“泻剂结肠”大鼠结肠肌电活动及其对乙酰胆碱反应的变化[J].第三军医大学学报, 2003, 25 (11):997-999.
12.张连阳,高峰,童卫东,等.大鼠泻剂结肠模型的建立[J].华人消化杂志, 1998, 6(10):864-866.
13. Seidel SA, Hegde SS, Bradshaw LA, et al. Intestinal tachyarrhythmias during small bowel ishchemia [J]. AM J Physiol, 1999, 277(5Pt1):G993-999.
14.张经济,连至诚.消化道生理及病理生理学[M].广州:广东科技出版社,1997, 1041-1106.
15. Ahmed S, Ali S. Electric activity spreads in the colonic longitudinal but not the circular musculature: Role in colonic motility[J]. Front Biosci, 2000, 5:5-8.
16. Shafik A, El-Sibai O, Mostafa RM, et al. Study of the mechanism of rectal motility: the mass squeeze contraction [J]. Arch Physiol Biochem, 2001, 109(5):418-423.
17.潘国宗,曹世植.肠道运动生理和检查方法,现代胃肠病学[M].第11版.北京:人民卫生出版社, 1994:1077.
18. Shafik A, El-Sibai O, Shafik AA, et al. Electric activity of the colon in irritable bowel syndrome: the tachyarrhythmic electric pattern [J]. J Gastroenterol Hepatol, 2004, 19(2): 205-210.
19.张永斌,邹移海,连至诚,等.溃疡性结肠炎大鼠模型及其结肠电异常[J].实验动物科学与管理, 2002,19(2):5-7.
20. Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene [J]. Mol Cell Endocrinol, 1997, 132:195-199.
21. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al. A novel isform of estrogen receptor beta with 18 amino acid insertion in the ligand binding dominant negative regulator of estrogen action [J].Biophys Res Commun, 1998, 246:142-147.
22. Petersen DN, Tkalcevic GT, Koza-Taylor PH, et al. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed innormal rat tissues [J]. Endocrinology, 1998, 139:1082-1092.
23. Price Jr RH, Lorenzon N, Handa RJ. Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variant missing exon 4[J]. Brain Res Mol, 2000, 80:260-268.
24. George G, Kuiper JM, Carlsson BO, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptorsαandβ[J]. Endocrinology, 1997, 138: 863-870.
25. Campbell-Thompson M. Estrogen Receptor a and b Expression in Gastrointestinal Tract with Regulation of Trefoil Factor Family 2 mRNA Levels in Ovariectomized Rats[J]. Biochemical and biophysical research communications, 1997, 240: 478-483.
1. Torihashi S, Fujimoto T, Trost C, et al. Calcium oscillation linked to pacemaking of interstitial cells of Cajal[J]. J Biol Chem, 2002, 277(21):19191-19197.
2. Sanders KM, Ordog T, Ward SM, et al. Physiology and pathophysiology of the interstitial cells of cajal: from bench to bedside IV [J]. Am J Physiol Gastrointest Liver Physiol, 2002, 282(5): G747-G756.
3. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation[J]. Gut, 2002, 51(4):496-501.
4. Wang XY, Vannucchi MG, Nieuwmeyer F, et al. Changes in interstitial cells of Cajal at the deep muscular plexus are associated with loss of distention induced burst-type muscle activity in mice infected by Trichinella spiralis[J]. Am J Pathol, 2005, 167: 437-453.
5. Ward SM, Sanders KM. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside I. Functional development and plasticity of interstitial cells of Cajal networks [J]. Am J Physiol Gastrointest Liver Physiol, 2001, 281(3):G602-611.
6. Sanders KM, Ordog T, Koh SD, et al. Development and plasticity of interstitial cells of Cajal[J]. Neurogastroenterol Motil, 1999, 11(5):311-338.
7. Kitamura Y, Hirota S, Nishida T. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis [J]. Mutat Res, 2001, 477(1-2):165-171.
8.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
9. Hogg A, Schirm S, Nakagoshi H, et al. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2[J]. Oncogene, 1997, 15(24): 2885-2898.
10. Campbell-Thompson M. Estrogen receptor a and b expression in gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats [J]. Biochemical and biophysical research communications, 1997, 240:478-483.
11. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectalbiopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8(12):1207-1211.
12. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3):143-150.
13. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48): 1540-1544.
14. Porter AJ, Wattchow DA, Hunter A, et al. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation[J]. Int J Colorectal Dis, 1998, 13(5-6):208-216.
15.童卫东,刘宝华,张胜本,等.顽固性慢传输性便秘的外科处理及病因研究[J].中华胃肠外科杂志, 2002, 5(4): 266-268.
16.童卫东,蔡文琴,张胜本. Cajal间质细胞研究进展[J].解剖科学进展, 1997, 3(2): 116-120.
17. Huizinga JD, Thuneberg L, Kluppel M, et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity[J]. Nature, 1995, 373(6512):347-349.
18. Rich A, Hanani M, Ermilov LG, et al. Physiological study of interstitial cells of Cajal identified by vital staining[J]. Neurogastroenterol Motil, 2002, 14(2):189-196.
19. Epperson A, Hatton WJ, Callaghan B, et al. Molecular markers expressed in cultured and freshly isolated interstitial cells of Cajal[J]. Am J Physiol Cell Physiol, 2000, 279(2): C529-539.
20. Burnstock G, Lavin S. Interstitial cells of Cajal and purinergic signalling[J]. Auton Neurosci, 2002, 97(1):68-72.
21. Nakahara M, Isozaki K, Hirota S, et al. Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus[J]. J Gastroenterol Hepatol, 2002, 17(6):666-670.
22. Porcher C, Baldo M, Henry M, et al. Deficiency of interstitial cells of Cajal in the small intestine of patients with Crohn's disease[J]. Am J Gastroenterol, 2002, 97(1):118-125.
23. Rolle U, Piotrowska AP, Nemeth L, et al. Altered distribution of interstitial cells of Cajal in Hirschsprung disease[J]. Arch Pathol Lab Med, 2002, 126(8):928-933.
24. Vanderwinden JM, Rumessen JJ, Liu H, et al. Interstitial cells of Cajal in human colon and in Hirschsprung's disease[J]. Gastroenterology, 1996, 111(4):901-910.
25. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitoryinnervation in insulin-dependent diabetes[J]. Gastroenterology, 2001, 121(2):427-434.
26. Tong WD, Liu BH, Zhang LY, et al. Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation[J].Int J Colorectal Dis. 2004, 19: 467-473.
27. Isozaki K, Hirota S, Miyagawa J, et al. Deficiency of c-kit cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction[J]. Am J Gastroenterol, 1997, 92(2):332-334.
28. Rich A, Miller SM, Gibbons SJ, et al. Local presentation of Steel factor increases expression of c-kit immunoreactive interstitial cells of Cajal in culture. Am J Physiol Gastrointest Liver Physiol [J], 2003, 284(2):G313-320.
29. Tong WD, Liu BH, Zhang LY, et al. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation [J]. Int J Colorectal Dis. 2005, 20: 363-367.
30. KrausWL, Mcinerney EM, Katzenellenbogen BS. Ligand-dependent tanscriptionally productive association of the amino-and carboxyterminal regions of a steroid hormone nuclear receptor [J]. Proc Natl Acad Sci USA, 1995, 92(12):314-318.
31. Mcinerney EM, Tsai MJ, O’Malley BW, et al. Analysis of estrogen receptor transcriptional enhancement by a nuclear receptor coactivator[J]. Proc Natl Acad Sci USA, 1996, 93(10): 069-073.
32. Cowley SM, Parker MG. A comparison of transcriptional activation by ER alpha and ER beta [J]. J Steroid Biochem Mol Biol, 1999, 69:165-175.
33. Barkhem T, Carlsson B, Nilsson Y, et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists[J]. Mol Pharmacol, 1998, 54:105-112.
34. Giaroni C, De Ponti F, Cosentino M, et al. Plasticity of the enteric nervous system[J]. Gastroenterology, 1999, 117:1438-1458.
35. Hanani M, Ledder O, Yutkin V, et al. Regeneration of myenteric plexus in the mouse colon after experimental denervation with benzalkonium chloride[J]. J Comp Neurol, 2003, 462:315-327.
36. Chang IY, Glasgow NJ, Takayama I, et al. Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction[J]. J Physiol (Lond).2001, 536:555-568.
1. Warner M, Nilsson S, Gustafsson JA. The estrogen receptor family[J]. Curr Opin Obs Gyn, 1999, 11 (3):249-254.
2. Gupta RR, Sen S, Diepenhorst LL, et al.Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats [J]. Brain Res, 2001, 888(2):356-365.
3. Ogawa, S, Chester AE, Hewitt SC, et al. Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO)[J]. Proc. Natl Acad Sci USA, 2000, 97( 26):14737-14741.
4. Hilakivi-Clarke L. Estrogens, BRCA1, and breast cancer[J]. Cancer Res, 2000, 60(18): 4993-5001.
5. Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA[J]. Science, 1986, 231:1150-1154.
6. Kuiper GG, Enmark E, Pelto-Huikko M, et al.Cloning of a novel estrogen receptors expressed in rat prostate and ovary[J]. Proc Natl Acad Sci USA, 1996, 93(12): 5925-5930.
7. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor[J]. FEBS Lett, 1996, 392(1):49-53.
8. Murphy LC, Dotzlaw H, Leygue E,et al. Estrogen receptor variants and mutations: a review[J]. J Steroid Biochem Mol Biol,1997, 62:363-372.
9. Poola I, Koduri S, Chatra S.et al. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targetedprimer approach [J]. J Steroid Biochem Mol Biol, 2000, 72(5):249-258.
10. Enmark E, Pelto-Huikko M, Grandien K, et al. Human Estrogen Receptor b-Gene Structure, Chromosomal Localization, and Expression Pattern[J]. J Clin Endocrinol Metab, 1997, 82(12):4258-4265.
11. Giguere V, Tremblay A, Tremblay GB. Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling [J]. Steroids, 1998, 63(5-6): 335-339.
12. Ogawa S, Inoue S, Watanabe T, et al. The Complete Primary Structure of Human Estrogen Receptor b (hERb) and its Heterodimerization with ERa in Vivo and in Vitro[J]. Biochem Biophys Res Commun, 1998, 243:122-126.
13. Dupont S, Krust A, Gansmuller A, et al. Effect of single and compound knockouts of estrogen receptors alpha (ER alpha) and beta (ER beta) on mouse reproductive phenotypes[J]. Development, 2000, 127:4277-4291.
14. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and Characterization of Human Estrogen Receptorβisoforms[J].Biochem Biophys Res Commun, 1998, 247:75-78.
15. Poola, I, Abraham, J, Baldwin, K, et al. Estrogen Receptors Beta 4 and Beta 5 Are Full Length Functionally Distinct ERβIsoforms [J]. Endocrine, 2005, 27:227-238.
16. Yuet-Kin Leung, Paul Mak, Sazzad Hassan, et al. Estrogen receptor ERβisoforms: A key to understanding ERβsignaling [J]. PNAS, 2006, 103(35):13162-13167.
17. Ogawa S,Inoue S, Watanabe T, et al. Molecular cloning and characterization of human estrogen. receptorβcx: a potential inhibitor of estrogen action in human[J]. Nucleic Acids Res, 1998, 6(15): 3505-3512.
18. Chu S, Fuller PJ. Identification of a splice variant of the rat estrogen receptor beta gene [J]. Mol Cell Endocrinol, 1997, 32:195-199.
19. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al.A novel isform of estrogen receptor beta with 18 amino acid insertion in the ligand binding dominant negative regulator of estrogen action,Biophys[J]. Res Commun, 1998, 246:142-147.
20. Petersen DN, Tkalcevic GT, Koza-Taylor PH, et al. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed innormal rat tissues [J]. Endocrinology,1998, 139:1082-1092.
21. Price Jr RH, Lorenzon N, Handa RJ. Differential expression of estrogen receptor beta splice variants in rat brain: identification and characterization of a novel variantmissing exon 4[J]. Brain Res Mol Brain Res, 2000, 80:260-268.
22. Maruyama K, Endoh H, Sasaki-Iwaoka H, et al. A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action [J]. Biochem Biophys Res Commun, 1998, 246:142-147.
23. George G, Kuiper JM, Carlsson BO, et al.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptorsαandβ[J]. Endocrinology, 1997, 138:863-870.
24. Fuqua SA, Schiff R, Parra I, et al. Expression of wild type estrogen receptor beta and variant isoforms in human breast cancer [J].Cancer Res, 1999, 59: (21) 5425-5428.
25. Iwao K, Miyoshi Y, Egawa C, et al. Quantitative analysis of estrogen receptor alpha and beta messenger RNA expression in breastcarcinoma by real-time polymerase chain reaction [J]. Cancer, 2000, 89 (8):1732-1738.
26. Leygue E, Dotzlaw H, Watson PH, et al. Expression of estrogenreceptor beta1 , beta2 , and beta5 messenger RNAs in human breast tissue[J].Cancer Res,1999,59(6): 1175-1179.
27. Campell-Thompson M, Jeanette L, Bhavna B. Expression of Estrogen Receptor (ER) subtyes and Isoform in Colon Cancer[J]. cancer research, 2001, 61(15): 632-640.
28. Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor beta in the brain: from form to function [J]. Brain Res Rev, 2007, 37:223-234.
29. Campbell-Thompson M. Estrogen receptor a and b expression in gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats [J]. Biochem Biophys Res Commun, 1997, 240:478-483.
30. Dardes RC, Jordan VC. Novel Agents to modulate oestrogen action[J]. Br Med Bull, 2000, 56 (3):773-786.
31. Fiorelli G, Picariello L, Martineti V, et al. Estrogen synthesis in human colon cancer epithelial cells [J]. J Steroid Biochem Mol Biol, 1999, 71 (526):223-230.
32. Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to anti apoptosis in breast cancer [J]. Mol Endocrinol, 2000, 14:1434-1447.
33. Kousteni S, Bellido T, Plotkin LI, et al. Nongeno-tropic, sex-nonspecific signaling through the estrogen or androgenreceptors: dissociation from transcriptional activity [J].Cell, 2001, 104: 719-730.
34. Razandi M, Pedram A, Greene GL, et al. Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERa and ERb expressed in CHO cells [J]. Mol Endocrinol, 1999, 13: 307-319.
35. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase[J]. Nature, 2000, 407:538-541.
36. Witte D, Chirala III, Younes A, et a1.Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Human Pathol, 2001, 32(9): 940-944.
37.张林,童卫东,刘宝华.慢传输型便秘患者乙状结肠雌激素β受体分布的免疫组化观察[J].第三军医大学学报, 2007, 29 (12): 1246-1248.
38. Foley EF, Jazari AA, Shupnik MA, et al. Selective loss of estrogen receptorβin malignant human colon[J ]. Cancer res, 2000, 60(2): 245-248.
39. Konstantinopoulos PA, Kominea A,Vandoros G, et al. Oestrogen receptor beta ( ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation[J]. Eur J Cancer, 2003, 39 (9):1251-1258.
40. Fiorelli G, Picariello L, Martinet V, et al. Functional estrogen receptorβin colon cancer cells.Biochem.Biophys[J].Res.Commun, 1999, 261(2): 521-527.
41. Arai N, Strom A, Rafter J, et a1. Estrogen receptorβmRNA in colon cancer cells: growth effects of estrogen and genistein[J]. Biochem Biophys Res Common, 2000, 270(2):425-431.
1. Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psycho- logical enquiry. Eur J Gastroenterol Hepatol [J], 2001,13(1):39-44.
2. Chattat R, Bazzocchi G, Balloni M, et al. Illness behavior , affective disturbance and intestinal transit time in idiopathic constipation[J].J Psychosom Res, 1997,42 (1): 95-100.
3. Emmanuel AV, Mason HJ, Kamm MA. Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder [J]. Gut, 2001, 49(3):209-213.
4.徐海珊,姜铀,战敏,等.慢性特发性便秘患者肛门直肠动力及精神心理因素的研究[J].临床内科杂志, 2001,18(9): 379-381.
5.刘海峰,何俊堂.慢传输便秘发病机制的研究进展.胃肠病学[J].2005, 10(6):379-381.
6. Vannucchi MG. Receptors in interstitial cells of Cajal: Idendification and possible p hysiological roles[J]. Microsc Res Tech,1999,47:325-335.
7. He CL, Burgart L, Wang L , et al. Decreased interstitial cell of cajal volume in patients with slow transit constipation[J]. Gastroenterology, 2000, 118(1):14-21.
8. Lyford GL, He CL, Softer E, et al. Pancolonic decrease in interstitial cells of Cajal in patients with slow transit constipation[J]. Gut, 2002, 51(4):496-501.
9. Wedel T, Spiegler J, Soetlner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow transit constipation and megaeolon. Gastroenterology [J], 2002, 123(5):1459-1467.
10. Torihashi S, Nishi K, Tokutomi Y, et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype [J]. Gastroenterology, 1999, 117(1):140-148.
11. Chang IY, Glasgow NJ, Takayama I, et al. Loss of interstitial cells of Cajal and development of electrical dysfunction in murine small bowel obstruction [J].J Physiol, 2001, 536:555-568.
12. Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation [J]. Hepatogastroenterology, 2002, 49(48):1540-1544.
13. Schouten WR, ten Kate FJ, de Graaf EJ, et al. Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament [J] .Dis Colon Rectum, 1993, 36(12):1112-1117.
14.张胜本,黄显凯,张连阳,等. 17例慢传输性便秘外科治疗分析[J].中华外科杂志.1999, 37(2):91-92.
15. Wedel T, Roblick UJ, Ott V, et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow transit constipation[J]. Dis Colon Rectum, 2002, 45(1):54-62.
16. Bassotti G, Villanacci V, Maurer CA, et al. The role of glial cells and apoptosis of enteric neurons in the neuropathology of intractable slow transit constipation[J]. Gut, 2006, 55:41-46.
17. Tzavella K, Riepl RL, Klauser AG, et al. Decreased substance P levels in rectal biopsies from patients with slow transit constipation [J]. Eur J Gastroenterol Hepatol, 1996, 8 (12):1207-1211.
18. Tomita R, Fujisaki S, Ikeda T, et al. Role of nitric oxide in the colon of patients with slow- transit constipation[ J]. Dis Colon Rectum, 2002, 45 (5):593-600.
19. Zhao RH, Baig MK, Mack J, et al. Alteredserotonin immunoreactivities in the left colon of patients with colonic inertia [J]. Colorectal Dis, 2002, 4 (1):56-60.
20. Zhao RH, Baig MK, Thaler KJ, et al.Reduced expression of serotonin receptor(s) in the left colon of patients with colonic inertia [J] . Dis Colon Rectum, 2003, 46(1): 81-86.
21. Ding JH, Fu CG, Zhao RH, et al. Serotonin transporter gene polymorphism in slow transit constipation [J]. Chinese Journal of Gastrointestinal Surgery, 2006, 9(4):328- 330.
22. Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopnthic chronic constipation (slow transit constipation) [J]. Neurogastroenterol Motil, 1997, 9(3): 143-150.
23. Krogh K, Mosdal C, Laurberg S. Gastrointestinal and segmental colonic transit times in patients with acute and chronic spinal cord lesions [J]. Spinal Cord, 2000, 38(10): 615-621.
24. Chia YW, Lee TKY, Kour NWet al. Microchip implants on the anterior sacral roots in patients with spinal trauma: does it improve bowel function[J]. Dis Colon Rectum, 1996, 39 (6):690-694.
25. Speakman CTM, Madden MV, Nicholls RJ, et al. Lateral ligament division during rectopexy causes constipation but prevents recurrenceresults of a prospective randomised study[J]. Br J Surg, 1991, 78:1431-1433.
26. Dan J HV, Gosselink MJ, Drogendijk AC, et al. Changes in bowelfunction after hysterectomy[ J]. Dis Colon Rectum, 1997, 40 (11):1342-1346.
27. Slater BJ, Varma JS, Gillespie JI. Abnormalities in the contractile properties of colonic smooth muscle in idiopathic slow transit constipation[J]. Br J Surg, 1997, 84(2): 181-184.
28. Park H J, Kamm MA, Abbasi AM, et al. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation[J]. Dis Colon Rectum, 1995, 38(5):509-513.
29. Knowles CH, Nickols CD, Scott SM, et al. Smooth muscle inclusion bodies in slow transit constipation [J]. J Pathol, 2001, 193(3):390-397.
30. Dufour P, Gendre P. Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration [J]. Gut, 1984, 25(12):1358-1363.
31. Tzavella K, Schenkirsch G, Riepl RL, et al. Effects of long term treatment withanthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon [J]. Eur J Gastroenterol Hepatol, 1995, 7(1): 13-20.
32.童卫东,张胜本,张连阳,等.长期应用大黄对大鼠结肠肌电及Cajal间质细胞的影响[J].第三军医大学学报, 2000, 22(4):351-353.
33. Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement[J]. Gastroenterology, 1997, 112:1366-1371.
34. Howe S, Eaker EY, Sallustio JE, et al. Antimyenteric neuronal antibodies inscleroderma [J]. J Clin Invest, 1994, 94:761-770.
35. Basilisco G, Barbera R, Vanoli M, et al. Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis[J]. Dig Dis Sci, 1993, 38: 1525-1529.
36. Lindberg G, Glia A, Nyberg B, et al. Lymphocytic Epithelioganglionitis-A new entity causing severe motility disorders of the gut[J]. Gastroenterology, 1999, 116:4476.
37. Smith VV, Milla PJ. Histological phenotypes of enteric smooth muscle disease causingfunctional intestinal obstruction in childhood[J]. Histopathology, 1997, 31: 112-122.
38. Peracchi M, Basilisco G, Tagliabue R, et al. Postprandial gut peptide plasma levels inwomen with idiopathic slow-transit constipation[J]. Scand-J-Gastroenterol, 1999, 34(1):25-28.
39. Penning C, Delemarre JB, Bemelman WA, et al.A Proximal and distal gut hormone secretion in slow transit constipation[J]. Eur-J-Clin-Invest, 2000, 30(8): 709-714.
40. Vander Sijp JR, Kamm MA, Nightingale JM, et al. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation[J]. Am J Gastroenterol, 1998, 93:1351-1356.
41. Enerson GT. Gastrointestinal motility in pregnancy[J]. Gastroenterrol Clin-North-Am, 1992, 21:751-776.
42. Jung HK, Kim DY, Moon IH. Effects of gender and menstrual cycle on colonict ransit time in Gastrointestinal motility in pregnancy[J]. Korean J Intern Med, 2003, 18(3): 181-186.
43. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy [J]. Ann Intern Med, 1993, 118(5):366-375.
44. Aytug N, Giral A, Imeryuz N, et al. Gender influence on jejunal migrating motor complex[J].Am J Physiol 2002, 280:G255-263.
45. Gill RC,Bowes KL,Kingma YJ. Effect of progesterone on canine colonic smooth muscle[J]. Gastroenterology, 1985, 88(6):1941-1947.
46.童卫东,刘宝华,张胜本.顽固性慢传输便秘的外科治疗及病因研究[J].中华胃肠外科杂志, 2002, 5(4):266-268.
47. Kamm MA, Farthing MJ, Lennard-Jones JE, et al. Steroid hormone abnormalities in women with severeid iopathic constipation[J]. Gut, 1991, 32(1):80-84.
48. Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy[J]. Am J Physiol, 1986, 251:G46-50.
49. Bielefeldt K, Waite L, Abboud FM, et al. Nongenomic effects of progesterone on human intestinal smooth muscle cells[J]. Am J Physiol, 1996, 271:G3702-3706.
50. Xiao ZL, Pricolo V, Biancani P, et al. Role of progesterone signaling in the regulation of G-protein levels infemale chronic constipation [J]. Gastroenterology, 2005, 128(3): 667-675.
51. Gonenne J, Esfandyari T, et al. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women [J]. Neurogastr-oenterol-Motil, 2006, 18(10):911-918.
52.尹淑慧.水通道与大肠内液体转运及便秘的关系[J].国际病理科学与临床杂志, 2005, 25(4):364-367.
53. El-Salhy M. Chronic idiopathic slow transit constipation: pathophysiology and Management [J]. Colorectal Dis, 2003, 5(4):288-296.
54. Ferguson A, Culbert P, Gillett H, et al. New polyethylene glycol electrolyte solution for the treatment of constipation and faecal impaction [J]. Ital J Gastroenterol Hepatol, 1999, 31(3):249-252.
55. Wildt S, Norby Rasmussen S, Lysgard Madsen J, et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test [J]. Scand J Gastroenterol, 2003, 38(8):826-830.
56. Sauter GH, Moussavian AC, Meyer G, et al. Bowel habits and bile acid malabsorptionin the months after cholecystectomy[J]. Am J Gastroenterol, 2002, 97(7):1732-1735.
57.熊理守,陈昊湖,陈惠新,等.广东省社区人群慢性便秘的流行病学研究[J].中华消化杂志, 2004, 24(8):488-491.
58.尉秀清.广州市居民功能性便秘流行病学调查[J].胃肠病学和肝病学杂志, 2001, 10(2):150-151.
59.阚志超.天津市成年人慢性便秘调查及相关因素分析[J].中华消化杂志, 2004, 24(10):612-614.
60. Pashankar DS, Loening-Baucke V. Increased prevalence of obesity in children with functional constipation evaluated in an academic medical center [J]. Pediatrics, 2005, 116(3):377-380.
61. Nakaji S, Tokunaga S, Sakamoto J, et al. Relationship between lifestyle factors and defecation in a Japanese population[J]. Eur J Nutr, 2002, 41(6):244-248.
62. Voderholzer WA, Schatke W, MfihldoHer BE, et al. Clinical response to dietary fiber treatment of chronic constipation[J]. Am J Gastroenterol, 1997, 92:95-98.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |